BioNTech (BNTX) PT Lowered to $158 at Canaccord
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $90.19 --0%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 13
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 13
Join SI Premium – FREE
Canaccord analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $158.00 (from $171.00) while maintaining a Buy rating.
You May Also Be Interested In
- Evercore ISI Downgrades Inspire Medical Systems (INSP) to In Line
- Eastroc Beverage Group Co (605499:CH) PT Lowered to RMB140.60 at Citi
- ENN Energy Holdings Limited (2688:HK) (XNGSY) PT Lowered to HK$47 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
